Erratum: Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood (Nature (2017) 548 (343-346) DOI: 10.1038/nature23451);Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood

Nature

Volumn 548, Issue 7667, 2017, Pages 343-346

  Joung, Julia ^a,b,c,d   Engreitz, Jesse M ^b   Konermann, Silvana ^b,c,d,g   Abudayyeh, Omar O ^b,c,d   Verdine, Vanessa K ^b,c   Aguet, Francois ^b   Gootenberg, Jonathan S ^b,c,d,e   Sanjana, Neville E ^b,c,d,h,i   Wright, Jason B ^b,c,d   Fulco, Charles P ^b,e   Tseng, Yuen Yi ^b   Yoon, Charles H ^f   Boehm, Jesse S ^b   Lander, Eric S ^b,d,e   Zhang, Feng ^a,b,c,d  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^h NEW YORK GENOME CENTER   (United States)

ⁱ NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GUIDE RNA; LONG UNTRANSLATED RNA; VEMURAFENIB; B RAF KINASE; BRAF PROTEIN, HUMAN; HIPPO PROTEIN, HUMAN; INDOLE DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN; MOB3B PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; SULFONAMIDE;

CANCER; CELLS AND CELL COMPONENTS; ENZYME; GENE; GENE EXPRESSION; GENOME; INHIBITOR; MAMMAL; PHENOTYPE; PROTEIN; RNA;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CRISPR CAS SYSTEM; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; RNA SEQUENCE; TRANSCRIPTION INITIATION; UPREGULATION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HUMAN GENOME; MELANOMA; METABOLISM; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

MAMMALIA;

CELL LINE, TUMOR; CRISPR-CAS SYSTEMS; DRUG RESISTANCE, NEOPLASM; GENETIC LOCI; GENOME, HUMAN; HUMANS; INDOLES; MELANOMA; MICROTUBULE-ASSOCIATED PROTEINS; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS B-RAF; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; SULFONAMIDES; TRANSCRIPTION INITIATION SITE; TRANSCRIPTIONAL ACTIVATION;

EID: 85027869993     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature24009     Document Type: Erratum

References (28)

1. Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
2. Cabili, M. N. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25, 1915-1927 (2011).
3. Wang, K. C. et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472, 120-124 (2011).
4. Engreitz, J. M. et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science 341, 1237973 (2013).
5. Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493, 231-235 (2013).
6. Anderson, K. M. et al. Transcription of the non-coding RNA upperhand controls Hand2 expression and heart development. Nature 539, 433-436 (2016).
7. Engreitz, J. M. et al. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature 539, 452-455 (2016).
8. Paralkar, V. R. et al. Unlinking an lncRNA from its associated cis element. Mol. Cell 62, 104-110 (2016).
9. Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583-588 (2015).
10. O'Leary, N. A. et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 44, D733-D745 (2016).
11. König, R. et al. A probability-based approach for the analysis of large-scale RNAi screens. Nat. Methods 4, 847-849 (2007).
12. Johannessen, C. M. et al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 504, 138-142 (2013). 10.1038/nature12688
13. Praskova, M., Xia, F. & Avruch, J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr. Biol. 18, 311-321 (2008).
14. Skalska, L., Beltran-Nebot, M., Ule, J. & Jenner, R. G. Regulatory feedback from nascent RNA to chromatin and transcription. Nat. Rev. Mol. Cell Biol. 18, 331-337 (2017).
15. Fulco, C. P. et al. Systematic mapping of functional enhancer-promoter connections with CRISPR interference. Science 354, 769-773 (2016).
16. Liu, S. J. et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science 355, aah7111 (2017).
17. Sanjana, N. E. et al. High-resolution interrogation of functional elements in the noncoding genome. Science 353, 1545-1549 (2016).
18. Zhu, S. et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat. Biotechnol. 34, 1279-1286 (2016).
19. Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protocols 12, 828-863 (2017).
20. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
21. Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
22. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
23. Rao, S. S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665-1680 (2014). 10.1016/j. cell.2014.11.021
24. Consortium, E. P.; ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
25. Felsenstein, J. & Churchill, G. A. A Hidden Markov Model approach to variation among sites in rate of evolution. Mol. Biol. Evol. 13, 93-104 (1996).
26. Konieczkowski, D. J. et al. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 4, 816-827 (2014).
27. Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108-112 (2009).
28. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-607 (2012).